AEON Biopharma, Inc. (AEON) Total Return Calculator with Dividends Reinvested

AEON Biopharma, Inc.

Popular:

The total return for AEON Biopharma, Inc. (AEON) stock is -18.09% over the past 12 months. So far it's down 34.18% this year. The 5-year total return is -99.89%, meaning $10,000 invested in AEON stock 5 years ago would be worth $11 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in AEON 1 year ago, it would be worth $8,020 today — you'd have lost $1,980.

With Dividends Reinvested$8,020-19.80%

Price Only (No DRIP)$8,020-19.80%

Period2025-06-13 → 2026-06-12

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in AEON

1Y$8,191-$1,809 (-18.1%)-18.1% CAGR

3Y$11-$9,989 (-99.9%)-89.7% CAGR

5Y$11-$9,989 (-99.9%)-74.4% CAGR

10Y$11-$9,989 (-99.9%)-49.4% CAGR

15Y$11-$9,989 (-99.9%)-36.5% CAGR

20Y$11-$9,989 (-99.9%)-28.9% CAGR

30Y$11-$9,989 (-99.9%)-20.3% CAGR

AEON Biopharma, Inc. did not pay dividends during this period. Total return = price return.

Loading AEON total return...

As of 2026-06-13

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-34.18%	—	-34.18%	—	$6,582
1Y	-18.09%	-18.09%	-18.09%	—	$8,191
3Y	-99.89%	-89.67%	-99.89%	—	$11
5Y	-99.89%	-74.38%	-99.89%	—	$11
10Y	-99.89%	-49.39%	-99.89%	—	$11
15Y	-99.89%	-36.49%	-99.89%	—	$11
20Y	-99.89%	-28.86%	-99.89%	—	$11
30Y	-99.89%	-20.31%	-99.89%	—	$11

Risk & Highlights

Best Year-21.74%2023

Worst Year-97.22%2025

Max Drawdown-52.00%2025-10-16 → 2025-12-05

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+0.90%	+0.90%	—	+0.41%	+0.5pp
2025	-97.22%	-97.22%	—	+16.64%	-113.9pp
2024	-92.73%	-92.73%	—	+24.00%	-116.7pp
2023	-21.74%	-21.74%	—	+24.81%	-46.6pp

AEON underperformed the S&P 500 by 40.95pp over the past year (-18.09% vs +22.86%).

Loading summary...

AEON Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
AEONAEON Biopharma, Inc.	$9M	-17.0%	-34.2%	-18.1%	—	-99.9%	-99.9%	-99.9%
REVBRevelation Biosciences, Inc.	$3M	-4.2%	-69.3%	-89.7%	—	-100.0%	-100.0%	-100.0%
NUVLNuvalent, Inc.	$9.1B	+20.2%	+22.2%	+58.2%	—	+183.3%	+557.3%	+557.3%
ACTUActuate Therapeutics Inc	$48M	-30.1%	-66.5%	-76.5%	—	-76.5%	-76.5%	-76.5%
ABBVAbbVie Inc.	$402.8B	+9.5%	+0.8%	+21.9%	+3.5pp	+79.3%	+123.7%	+362.2%
ALNYAlnylam Pharmaceuticals, Inc.	$37.7B	-3.1%	-29.3%	-7.2%	—	+46.5%	+69.7%	+366.4%
INVAInnoviva, Inc.	$1.7B	+0.0%	+14.4%	+6.3%	—	+69.7%	+77.9%	+108.1%
IQVIQVIA Holdings Inc.	$30.8B	+3.7%	-19.5%	+14.0%	—	-14.4%	-25.8%	+177.5%
CRLCharles River Laboratories International, Inc.	$9.0B	+11.2%	-7.4%	+23.5%	—	-8.7%	-47.2%	+122.4%
MEDPMedpace Holdings, Inc.	$13.3B	+11.3%	-18.2%	+53.7%	—	+114.4%	+160.4%	+1581.7%
ICLRICON Public Limited Company	$11.2B	+19.9%	-22.5%	-0.6%	—	-35.9%	-32.0%	+120.9%

Compare:AEON vs REVB AEON vs NUVL AEON vs ACTU AEON vs REVB vs NUVL

About AEON Dividend Returns

AEON Biopharma, Inc. (AEON) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of AEON over the past year?

AEON Biopharma, Inc. (AEON) delivered a return of -18.09% over the past year. Since AEON does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in AEON be worth today?

A $10,000 investment in AEON Biopharma, Inc. one year ago would be worth $8,191 today, representing a loss of $1,809.

Q3Does AEON pay dividends?

AEON Biopharma, Inc. (AEON) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For AEON, the total return equals the price-only return.

Q4Did AEON beat the S&P 500?

No, AEON Biopharma, Inc. (AEON) underperformed the S&P 500 by 40.95 percentage points over the past year. AEON delivered a total return of -18.09%, compared to the S&P 500's 22.86%. This means a passive S&P 500 index fund outperformed AEON by 40.95pp during this period.

Q5What is AEON's worst drawdown?

AEON Biopharma, Inc. (AEON) experienced a maximum drawdown of -52.00% over the past year, declining from its peak on 2025-10-16 to its trough on 2025-12-05. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is AEON's long-term total return over 10, 20, or 30 years?

Here are AEON Biopharma, Inc. (AEON)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.9% (-49.4% CAGR) — $10,000 would have grown to $11. Over 20 years: -99.9% total return (-28.9% CAGR) — $10,000 → $11. Over 30 years: -99.9% total return (-20.3% CAGR) — $10,000 → $11. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was AEON's best and worst year?

AEON Biopharma, Inc.'s best calendar year was 2023 with a total return of -21.7%. Its worst year was 2025 with a total return of -97.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 75.5 percentage points.

How much would $100/month in AEON be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →